
Giant cell tumor (GCT) of bone is a locally aggressive neoplasm that most commonly affects the long bones. Involvement of the craniofacial skeleton is uncommon, and maxillary involvement is particularly rare. We report a case of a 13-year-old girl who presented with a progressively enlarging left cheek swelling. The lesion was removed through a sublabial approach by excision followed by curettage of the cavity. Histopathological examination supported the diagnosis of giant cell tumor. At 16 months, the patient had no clinical evidence of recurrence.
This study designed to evaluate styloid process (SP) length in temporomandibular joint ankylosis (TMJA) patients and compare with normal SP length. A retrospective study was planned to evaluate SP length in TMJA patients using computed tomography of face. The primary objective was to observe SP length in TMJA patients and compare with normal SP length(30 mm). Secondary objectives were to look for association with duration and aetiology of ankylosis, and to compare between unilateral and bilateral TMJA. The study sample had 100 patients. The mean length of SP on right side is 37.89 mm ± 2.94 and left is 38.32 mm ± 2.9. Statistically significant difference was observed with normal SP length(p = 0.00) and recurrent cases (right TMJA, p = 0.018, left TMJA, p-0.008). SP on left side was significantly longer than right in unilateral TMJA (Right TMJA, p = 0.12, Left TMJA = 0.012). SP length was greater in male patients when compared with female (right TMJA, p = 0.0096, left TMJA, p = 0.0035). There is positive correlation of ankylosis duration with SP length (right TMJA, p = 0.032, left TMJA, p = 0.005). The study concludes that SP is elongated in TMJA patients. This can interfere with counterclockwise rotation of maxillomandibular complex (MMC). Thus, removal of lower part of SP may be considered in TMJA patients with rotation of MMC.
Oral Submucous fibrosis is a chronic potentially malignant condition that leads to restricted mouth opening and significantly affects the patient’s quality of life. It has been observed that despite surgical intervention some patients complaint of unsatisfactory improvement in mouth opening. In one of such patients that reported to our institute with reduced mouth opening, the TMJ view showed a calcified projection at the insertion of lateral pterygoid muscle on the mandibular condyle. CBCT scan revealed a calcific focus in the region of lateral pterygoid muscle. We hypothesise that the calcific focus in the region of lateral pterygoid muscle can be attributed to the constant pull from the masticatory muscle. As this was a single case observation, confirming or refuting this hypothesis will require a prospective series of OSMF patients with persistent post-surgical trismus. We recommend a multicentre study with CBCT or equal cross-sectional imaging and ruling out alternative causes.
Plexiform neurofibroma is a benign tumor arising from nerve sheath cells. It is usually congenital but may not become apparent for years and strongly associated with Neurofibromatosis type 1 (NF1) in majority of cases.Around one third cases occur in craniofacial region, lip being a very uncommon sub site. It is a clinical diagnosis with biopsy demonstrating classic histologic characteristics. We report a rare case of plexiform neurofibroma involving both cutaneous and mucosal aspects of lower lip in a 19 year old male patient. There was no evidence of NF 1 and no family history. We did not come across similar case in electronic search of Pubmed database. The patient underwent conservative excision of the lesion for aesthetic concerns and is recurrencefree at 18 months follow up.
Glucagon-like peptide-1 receptor agonists (GLP-1RAs), particularly semaglutide and tirzepatide, have introduced new perioperative considerations in oral and maxillofacial surgery because of their effects on gastric emptying and aspiration risk. A structured narrative review was conducted using PubMed/MEDLINE, Scopus, ScienceDirect, and SciELO to identify studies published between 2019 and 2026 addressing perioperative management of GLP-1RA users undergoing surgery. Evidence indicates that GLP-1RAs may increase residual gastric contents despite standard fasting, particularly during procedures requiring sedation or general anaesthesia. Most recommendations are based on observational studies, guidelines, and expert consensus, with limited evidence specific to oral and maxillofacial surgery. Individualised perioperative assessment considering gastrointestinal symptoms, anaesthetic modality, and surgical complexity appears preferable to universal discontinuation strategies. Prospective oral and maxillofacial surgery–specific studies are needed to establish perioperative protocols.